The issue raised by the study has implications on current responses to HIV, since “informal use would increase risk for inconsistent drug access, unmonitored restarts, use when unknowingly infected, and compromised or counterfeit pills in the supply chain,” the authors stressed. As such, “MSM are urgently in need of culturally relevant knowledge about the efficacious use of PrEP as well as clear avenues of access for the medication.”